Chemoinformaics analysis of INDOLE-3-PROPIONIC-ACID
| Molecular Weight | 355.437 | nRot | 6 |
| Heavy Atom Molecular Weight | 334.269 | nRig | 23 |
| Exact Molecular Weight | 355.157 | nRing | 4 |
| Solubility: LogS | -4.513 | nHRing | 1 |
| Solubility: LogP | 5.044 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 3 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 21 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 22 |
| nHA | 1 | APOL | 56.7867 |
| nHD | 2 | BPOL | 22.5053 |
| QED | 0.489 |
| Synth | 2.141 |
| Natural Product Likeliness | 0.243 |
| NR-PPAR-gamma | 0.984 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.356 |
| HIA | 0.027 |
| CACO-2 | -5.183 |
| MDCK | 0.00002 |
| BBB | 0.162 |
| PPB | 0.992655 |
| VDSS | 0.4 |
| FU | 0.0084308 |
| CYP1A2-inh | 0.188 |
| CYP1A2-sub | 0.823 |
| CYP2c19-inh | 0.151 |
| CYP2c19-sub | 0.692 |
| CYP2c9-inh | 0.56 |
| CYP2c9-sub | 0.763 |
| CYP2d6-inh | 0.915 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.041 |
| CYP3a4-sub | 0.852 |
| CL | 2.256 |
| T12 | 0.451 |
| hERG | 0.091 |
| Ames | 0.052 |
| ROA | 0.015 |
| SkinSen | 0.609 |
| Carcinogencity | 0.268 |
| EI | 0.312 |
| Respiratory | 0.87 |
| NR-Aromatase | 0.065 |
| Antiviral | Yes |
| Prediction | 0.577628 |